1 — U.S. Stocks Set for Muted Open U.S. stock futures were mixed Wednesday morning after the Dow Jones Industrial Average notched another record close amid a broader transition away from tech stocks and into...
Stocks are set to rise for a second trading day despite a record number of new Covid cases that resulted in more than 1 million new infections across the U.S. on Monday. Verizon and AT&T , meantime, acquiesce to a...
It’s a good omen that U.S. stocks rose on the first trading day of 2022 — just not a meaningful one. Despite the claims made by some exuberant bulls, the odds the stock market will rise for all of 2022 are only barely...
Welcome back from your staycation. It’s time to make money. The markets enter the New Year in a great mood. Strategists are rocking 5,000-plus calls for year-end S&P 500 targets. What pandemic (said tongue-in-cheek)...
Investors can expect a busy first week of 2022, laden with key economic releases out of Washington that include the highly-anticipated December jobs report and minutes from the Federal Open Market Committee’s (FOMC)...
Warren Buffett’s Berkshire Hathaway portfolio provides a mix of legacy and current investments. Consequently, the portfolio consists of stocks that make sense as a hold but are less attractive to new buyers...
Chairman Jerome Powell (pictured) and the other policymakers at the Federal Reserve just said again, after their recent December meeting, that they’ll keep holding a key interest rate near zero. But only for now...
Global shares traded steadily on Friday, on the final trading day of 2021, which has seen stocks hit all-time highs.Most Asian and European markets were closed for the New Year’s holiday, but the FTSE 100 was down...
Check out the companies making headlines before the bell: Biogen (BIIB) – Biogen slid 6.5% in the premarket after Samsung denied a report in the Korea Economic Daily publication that it was in talks to...
Stock futures bump higher following another set of record highs; Biogen shares slide as Samsung BioLogics denies takeover report; Johnson & Johnson booster significantly reduces Omicron hospitalization risk; Didi...